RESOURCE / PUBLIC SOURCE RECORD
Invest in Norway: Health and life science
- The page describes Norway’s high healthcare investment per person, universal care, strong cancer research, personalized medicine, AI, health registries and trusted medical data. It highlights radiopharmaceutical production and research, including the potential for thorium-based treatments, Oslo’s Radium Hospital, Oslo Cancer Cluster and Life Science Cluster, and neuroscience groups in Oslo and Trondheim.
- Opportunities include digital care and ambient-assisted living, medical imaging and ultrasound, sensor and quantum technologies, secure registry data, Arctic and remote-care testing, and clinical trials. It points to GE HealthCare, NTNU’s Centre for Innovative Ultrasound Solutions, Oslo University Hospital’s Intervention Centre, the Norwegian Centre for E-health Research, Laerdal Medical, NorTrials and Nordic Proof. Invest in Norway offers industry information, networks and site-selection help.
- Public contacts: Gard Madsen, Director of Investment, Oslo (gard.madsen@innovasjonnorge.no; +47 909 37 833); Rasmus Malmborg, Investment Manager for Health and life science, Oslo (rasmus.malmborg@innovasjonnorge.no; +47 951 21 480); Jannik Grodt Schmidt, Investment Manager for Health and life science, New York (jannik.grodt.schmidt@innovationnorway.no; +1 917 972-6387; LinkedIn: linkedin.com/in/jannikschmidt82/); Rita Østbø Stobbs, listed as on maternity leave, Rogaland/Stavanger (Rita.Ostbo.Stobbs@innovasjonnorge.no; +47 463 33 649).
- No event listings or participation fees are displayed.